InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.19
(
0.07%
)
US TECH 100
19,376.00
(
-0.14%
)
Dow Jones
38,749.71
(
-0.07%
)
Brent Oil
84.45
(
0.65%
)
Bitcoin
64,635.30
(
-2.78%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rkp72

Send PM Follow Ignore
Followers 0
Posts 24
Boards Moderated 0
Alias Born 10/28/2013

rkp72

Re: Nomo123 post# 14677

Tuesday, 10/29/2013 10:32:02 AM

Tuesday, October 29, 2013 10:32:02 AM

Post# of 30990
Completely agree after having invested in some patent infringement cases. STSI's tobacco manufacturing patents are also a case in point. What did STSI get in the end after a decade of litigation. The risk of a work-around for manufacturing patents is always high.

For more beneficial for STSI would be approval for the "use" patent. This is when I believe that pharma interest will really start to open up.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up